.png)
TL;DRATC code stands for Anatomical Therapeutic Chemical code, the classification the World Health Organization uses to group active substances according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties. Each substance receives a code across five hierarchical levels.
The system is maintained by the WHO Collaborating Centre for Drug Statistics Methodology in Oslo, based at the Norwegian Institute of Public Health. The Centre assigns new codes, decides alterations, and publishes the complete index once a year, paired with the Defined Daily Dose. The ATC code is the backbone of international drug utilisation statistics, and it is the axis along which a professional can compare substances across markets that otherwise use different trade names and identifiers.
The code reads from left to right, from the broadest anatomical group down to the single substance. Levels two, three and four can represent a therapeutic, pharmacological or chemical subgroup depending on the group, but the canonical sequence is fixed. Ibuprofen, coded M01AE01, shows each level in turn.
| Level | Meaning | Ibuprofen example |
|---|---|---|
| 1 | Anatomical main group | M, Musculo-skeletal system |
| 2 | Therapeutic subgroup | M01, Antiinflammatory and antirheumatic products |
| 3 | Pharmacological subgroup | M01A, Antiinflammatory and antirheumatic products, non-steroids |
| 4 | Chemical subgroup | M01AE, Propionic acid derivatives |
| 5 | Chemical substance | M01AE01, ibuprofen |
Read in full, M01AE01 places ibuprofen in the musculo-skeletal group, among the non-steroidal antiinflammatory and antirheumatic products, in the propionic acid derivatives, as the specific substance. There are fourteen anatomical main groups at the first level, which is why every ATC code opens with one of fourteen letters.
The classification is not static. The WHO Collaborating Centre reviews requests and assigns codes and doses through the year, then packages the changes into a single annual update.
The Defined Daily Dose (DDD) is the companion concept. WHO defines it as the assumed average maintenance dose per day for a drug used for its main indication in adults. For ibuprofen the DDD is 1.2 g for the oral route. The DDD is a fixed unit of measurement for comparing drug consumption between substances and between countries, not a recommended prescribing dose, and only one DDD is assigned per ATC code and route of administration.
Yes. WHO states that a medicinal substance can be given more than one ATC code if it is available in two or more strengths or routes of administration with clearly different therapeutic uses. Finasteride is the standard example: the low-dose tablet for male pattern baldness sits under D11AX, and the higher-dose tablet for benign prostatic hyperplasia under G04C. A single fifth-level code therefore identifies a use, not simply a molecule, which matters when you map codes back to products.
On pharmazie.com the full WHO ATC tree is carried on the article detail page, and the ATC-Code (WHO) is one of the facet filters that narrows a parallel search across the connected databases. That makes the ATC code both a data point on the individual article and a search axis across the whole result set.
One honest limitation: the ATC code is assigned by WHO, not by any database. A substance approved very recently may not yet carry a fifth-level code, because a new code only becomes valid in the annual January update. In that window the tree can stop at a higher level, and no aggregator can fill a code the WHO has not yet issued.
